STING1 and neoplasm: While the importance of DNA sensing by the cGAS/STING pathway in treatment-induced IFN-I production has been well established (2–4), the mechanisms by which IFN-I signaling reprograms cell populations in the tumor microenvironment (TME) warrant further investigation.